Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working
Conditions: Locally Advanced Leiomyosarcoma; Metastatic Leiomyosarcoma; Stage III Uterine Corpus Leiomyosarcoma AJCC v8; Stage IV Uterine Corpus Leiomyosarcoma AJCC v8; Unresectable Leiomyosarcoma; Uterine Corpus Leiomyosarcoma Interventions: Drug: Olaparib; Drug: Pazopanib; Drug: Temozolomide; Drug: Trabectedin Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 27, 2022 Category: Research Source Type: clinical trials
Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma, Part 2
Condition: Leiomyosarcoma Intervention: Other: Blood samples will be collected at different times. Sponsors: Institut Claudius Regaud; Fondation ARC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2022 Category: Research Source Type: clinical trials